Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Generating income for early retirement is crucial. Discover various methods to boost your funds and ensure a stable financial future.
20,985 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
The Digital Chamber filed a lawsuit against Illinois over a 0.2% tax on digital asset transactions, arguing the levy ...
Joby Aviation is set to report Q4 2025 results after the close, and the focal point for investors is cash burn. The c...
Carvana’s stock run looked extraordinary, up 4,300% in three years. But the strongest buy signal wasn’t the hype—it w...
A billionaire investor backed D-Wave Quantum in late 2024, and the stock has surged and slumped in a choppy 2026 trad...
Three active AI-focused ETFs are pulling ahead as corporate AI investments surge. This report explains why after mont...
Retail investors sold NVIDIA, Microsoft, and Oracle to fund SpaceX private rounds, signaling a major shift in how eve...
The AI inference market could surge to about $255 billion by 2030 as demand for real-time AI services climbs. Learn w...
Can Netflix grow from its current scale to a trillion-dollar market value? This article breaks down the unlikely path...
A seasoned journalist spends a year letting AI handle routine work, finding strong productivity gains but ongoing rel...
The AI race is heating up, and anthropic (claude) only trillion is a headline that won’t fade. This article breaks do...
In a red-hot market, the lender with the quickest, most confident decision wins the land deal. A data-driven approach...